Skip to content
10-Q

Quarterly Report

IDEAYA Biosciences, Inc. IDYA

0001193125-25-264632

← back to feed
Filed
Nov 4, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Oct 31, 2025 87.67M sh
Shares Diluted Q3 2025 · Sep 30, 2025 89.69M sh
Shares Diluted Q3 2025 · Sep 30, 2025 88.45M sh
Shares Diluted Q3 2025 · Sep 30, 2024 86.19M sh
Shares Diluted Q3 2025 · Sep 30, 2024 79.78M sh
Capex Q3 2025 · Sep 30, 2025 $2.04M
Capex Q3 2025 · Sep 30, 2024 $2.76M
Operating Cash Flow Q3 2025 · Sep 30, 2025 $19.4M
Operating Cash Flow Q3 2025 · Sep 30, 2024 −$125.93M
Cash And Equivalents Q3 2025 · Sep 30, 2025 $298.93M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $84.38M
Cash And Equivalents Q3 2025 · Sep 30, 2024 $400.28M
Stockholders Equity Q3 2025 · Sep 30, 2025 $1.09B
Stockholders Equity Q3 2025 · Jun 30, 2025 $959.65M
Stockholders Equity Q3 2025 · Dec 31, 2024 $1.06B
Stockholders Equity Q3 2025 · Sep 30, 2024 $1.18B
Stockholders Equity Q3 2025 · Jun 30, 2024 $931.66M
Stockholders Equity Q3 2025 · Dec 31, 2023 $621.09M
Current Liabilities Q3 2025 · Sep 30, 2025 $64.51M
Current Liabilities Q3 2025 · Dec 31, 2024 $46.07M
Total Liabilities Q3 2025 · Sep 30, 2025 $93.1M
Total Liabilities Q3 2025 · Dec 31, 2024 $64.94M
Current Assets Q3 2025 · Sep 30, 2025 $802.66M
Current Assets Q3 2025 · Dec 31, 2024 $689.71M
Total Assets Q3 2025 · Sep 30, 2025 $1.19B
Total Assets Q3 2025 · Dec 31, 2024 $1.12B
Eps Diluted Q3 2025 · Sep 30, 2025 $1.33
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.34
Eps Diluted Q3 2025 · Sep 30, 2024 −$0.60
Eps Diluted Q3 2025 · Sep 30, 2024 −$1.81
Eps Basic Q3 2025 · Sep 30, 2025 $1.35
Eps Basic Q3 2025 · Sep 30, 2025 −$0.34
Eps Basic Q3 2025 · Sep 30, 2024 −$0.60
Eps Basic Q3 2025 · Sep 30, 2024 −$1.81
Sga Expense Q3 2025 · Sep 30, 2025 $16.39M
Sga Expense Q3 2025 · Sep 30, 2025 $44.47M
Sga Expense Q3 2025 · Sep 30, 2024 $9.74M
Sga Expense Q3 2025 · Sep 30, 2024 $28.35M
Rd Expense Q3 2025 · Sep 30, 2025 $82.99M
Rd Expense Q3 2025 · Sep 30, 2025 $228.11M
Rd Expense Q3 2025 · Sep 30, 2024 $57.15M
Rd Expense Q3 2025 · Sep 30, 2024 $154.49M
Net Income Q3 2025 · Sep 30, 2025 $119.24M
Net Income Q3 2025 · Sep 30, 2025 −$30.43M
Net Income Q3 2025 · Sep 30, 2024 −$51.82M
Net Income Q3 2025 · Sep 30, 2024 −$144.17M
Operating Income Q3 2025 · Sep 30, 2025 $108.45M
Operating Income Q3 2025 · Sep 30, 2025 −$64.74M
Operating Income Q3 2025 · Sep 30, 2024 −$66.89M
Operating Income Q3 2025 · Sep 30, 2024 −$182.84M
Revenue Q3 2025 · Sep 30, 2025 $207.83M
Revenue Q3 2025 · Sep 30, 2025 $207.83M